KBP-2010 - 1

Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: the KBP-2000-CPHG and KBP-2010-CPHG cohorts

Didier Debieuvre, Mulhouse

Chrystèle Locher (Meaux), Sylvie Vuillermoz-Blas (Lyon), Jacky Crequit (Creil), Edith Maetz (Douai), Anne Brichet-Martin

(Roubaix), David Renault (Morlaix), Jean-Yves Le Tinier (Bligny), Gérard Oliviero (Longjumeau), Jérôme Virally (Aulnay),

Sébastien Larive (Macon), Michel Grivaux (Meaux)

KBP-2010 - 2

Conflicts of Interest

Employment or Leadership Position:   None  

Consultant or Advisory Role:   None  

Stock Ownership:   None  Honoraria:   None  Research Funding:   Roche, AstraZeneca, Amgen, Lilly, AB sciences, Transgene,

Stallergene, BMS, Boehringer Ingelheim, Chugai, Pierre Fabre, Pfizer, MSD, Novartis, GSK, Sanofi Aventis  

Expert Testimony:   AstraZeneca, Novartis, Vifor, Roche, Boehringer Ingelheim Patents:   None  Other Remuneration (Invited Conferences and Congress):  

AstraZeneca, Amgen, Janssen, Lilly, Roche, GSK, Sanofi Aventis, Pierre Fabre, MSD, Boehringer Ingelheim, Novartis, Pfizer  

è No real or perceived, conflicts of interest that relate to this oral presentation.

KBP-2010 - 3

Introduction

•  Background: -  In 2000 and 2010, the CPHG performed KBP-2000-CPHG and

KBP-2010-CPHG, 2 prospective multicentre cohort studies that included 1 in 5 primary lung cancers diagnosed in France in 2000 and 2010.

-  These studies confirmed the change in patients’ and lung cancer characteristics: more women, never-smokers, and adenocarcinomas.

•  Objective: -  To review the evolution of NSCLC characteristics in male patients in 10 years.

KBP-2010 - 4

2000 2010 Sponsor: •  French College of General Hospital Respiratory Physicians (CPHG)

Scientific committee:

•  Chairman

•  Scientific secretaries

•  Other members

•  F. Blanchon, Meaux

•  T. Collon, Montfermeil •  M. Grivaux, Meaux

•  H. Barbieux, Roubaix •  M. Bénichou-Flurin, Pau •  J.-L. Breton, Belfort •  D. Coëtmeur, St-Brieuc •  B. Delclaux, Troyes •  J. Piquet, Montfermeil

•  M. Grivaux, Meaux

•  C. Locher, Meaux •  D. Debieuvre, Mulhouse

•  B. Asselain, Paris •  F. Blanchon, Meaux •  D. Coëtmeur, St-Brieuc •  T. Collon, Montfermeil •  C. Dayen, St-Quentin •  F. Goupil, Le Mans •  J. Le Treut, Aix en Provence •  F. Martin, Compiègne •  O. Molinier, Le Mans

Study centres: Investigators:

•  Respiratory medicine departments in a general hospital •  Physicians practicing in the respiratory medicine department

Organisation

KBP-2010 - 5

Methods

•  Inclusion criteria: ü  Age ≥ 18 years, ü  Primary lung cancer diagnosed histologically or cytologically

from 01-Jan-2000 to 31-Dec-2000 and from 01-Jan-2010 to 31-Dec-2010 (date of sampling),

ü  Followed-up in the respiratory department of one of the participating French general hospitals,

ü  Oral informed consent.

•  A standardised form was completed for each patient.

•  Collected data: patient characteristics and tumour characteristics and management at inclusion.

•  A steering committee checked recruitment exhaustiveness in each centre and all centres together.

KBP-2010 - 6

Study population

KBP-2000-CPHG

Centres: 137 Patients: 5667 (N ≈ 41/centre)

NSCLC: 4720 (N ≈ 34/centre)

Male: 3921 (N ≈ 29/centre)

KBP-2010-CPHG

Centres: 104 Patients: 7051 (N ≈ 68 /centre)

NSCLC: 6101 (≈ 59/centre)

Male: 4597 (N ≈ 44/centre)

In 2000, 83.1% of men among NSCLC patients

In 2010, 75.3% of men among NSCLC patients

KBP-2010 - 7

Age at diagnosis

64.4 years in 2000 vs. 65.7 years in 2010 (p < 0.0001)

p < 0.0001

% of male patients

KBP-2010 - 8

Smoking

p < 0.0001

Former-smokers, cessation: 11 years in 2000 vs. 15.3 years in 2010 % of male patients

KBP-2010 - 9

Tumour stage % of male patients

p < 0.0001

KBP-2010 - 10

Histology % of male patients

N: mean number of cases of NSCLC in male patients diagnosed in each centre

p < 0.0001

KBP-2010 - 11

Occupational exposure % of male patients

p < 0.0001

KBP-2010 - 12

First therapeutic strategy

p < 0.0001 p = 0.04

p < 0.0001

p = 0.02

% of male patients

KBP-2010 - 13

•  Male patients’ and lung cancer characteristics have changed in 10 years: -  Patients are older and more frequently never-smoker -  Tumour are more frequently metastatic or extended -  Adenocarcinoma is the most frequently reported histology in 2010

•  NSCLC is still a men disease (75.3%) and a smoker disease (49%).

•  In daily clinical practice, the number of squamous-cell carcinomas diagnosed in the respiratory departments of the French general hospitals remains stable.

•  The increase of adenocarcinoma in male patients reflects possibly the emergence of a “new” lung cancer. This hypothesis deserves further analysis.

Conclusion

KBP-2010 - 14

Aknowledgments

Created in January 2010 (SPLF, CPHG, FFP, …)

KBP-2010 - 15

Investigators CENTRES INVESTIGATEURS CENTRES INVESTIGATEURS CENTRES INVESTIGATEURS Abbeville O LELEU Douai E MAETZ Morlaix D RENAULT Aix-en-Provence J LE TREUT Draguignan J-R BARRIERE Moulins H BELHADJ Albi B BORREL Dreux F MARTIN Mulhouse P BOMBARON Angoulême-Saint-Michel M MARTIN Eaubonne F DENIEL Nanterre M SAILLOUR Annecy S HOMINAL Elbeuf-Louviers-Val-de-Reuil P DAVID Nevers D HERMAN Antibes-Juan-Les-Pins C MOUROUX-ROTOMONDO Epernay M CARBONNELLE Niort M D ARLHAC Argentan C DUBOS-ARVIS Epinal J-L COLLIGNON Nouméa-Nouvelle-Calédonie G FESQ Argenteuil H DE CREMOUX Evreux H MAHMOUD Oloron-Sainte-Marie E DE GROOTE Arras Y LIERMAN Fougères A MERZOUG Orléans B LEMAIRE Aubagne M IRISSON Fréjus-Saint-Raphaël D BOUDOUMI Paimpol G PERRUS Aubenas P DION Gap P THOMAS Papeete-Tahiti P FERRER LOPEZ Aulnay-sous-Bois J VIRALLY Granville-Avranches V TIZON Paray-le-Monial C GENETY Auxerre H BARBIEUX Grasse M FIGUEREDO Pau P-A RENAULT Bar-le-Duc P TAGU Guingamp K BADOUR Périgueux S LACROIX Bastia-Furiani J-C MOURIES Hénin-Beaumont E FOURNIER Perpignan D CHOMA Bayonne J-P MATHIEU Lagny-sur-Marne A BEDOSSA Pontoise G FRABOULET Belfort-Montbeliard D DEBIEUVRE La-Rochelle D LEMERRE Quimper H GALLOUX Bergerac L PORTEL La-Roche-sur-Yon J BERRUCHON Rodez S JULIEN Béziers F GOUTORBE Le-Chesnay-Versailles C DUJON Roubaix F STEENHOUWER Bourg-en-Bresse P BEYNEL Le-Coudray-Chartres O RAFFY Saint-Brieuc D COETMEUR Bourges G ADAM Le-Havre M PEUREUX Sainte-Feyre S JEANDEAU Bourgoin-Jallieu B GENTIL LE PECQ Le-Mans F GOUPIL Saint-Germain-en-Laye-Poissy S JOUVESHOMME Briey B REMIGNON Lens O FLOREA Saint-Malo E GOARANT Briis-sous-Forges-Bligny J-Y LE TINIER Libourne J-M MARCOS Saint-Nazaire D SANDRON Cahors P BARRE Longjumeau G OLIVIERO Saint-Pierre-Réunion F PAGANIN Cannes Y DUVAL Lons-le-Saunier M PERRICHON Saint-Quentin E LECUYER Chalons-en-Champagne G BERTHIOT Lourdes J-P VABRE Salon-de-Provence B KASSEYET-KALUME Chambéry V FRAPPAT Lyon-Desgenettes J-M DOT Saverne F BROLLY Charleville-Mézières S CHOUABE Lyon-St-Joseph-St-Luc S VUILLERMOZ-BLAS Sedan G-J KASSEM Chateauroux F LAMOTTE Mâcon S LARIVE Soissons M-G LEGRAND-HOUGNON Chaumont B SIMON Mantes-la-Jolie J-B AULIAC Thionville P BOTRUS Chauny P DUMONT Martigues M BELKAÏD Thonon-Les-Bains P ROMAND Chevilly-Larue K DE LUCA Meaux C LOCHER Troyes B DELCLAUX Cholet P MASSON Melun J-P DI MERCURIO Valence R RIOU Colmar J-P OSTER Metz N PAILLOT Vesoul D DEBIEUVRE Compiègne S DEHETTE Meulan-les-Mureaux E LEROY-TERQUEM Vienne C MARICHY Corbeil-Essonnes O SALMON Montargis T BENAICHA Villefranche-sur-Saône L FALCHERO Creil P LE LANN Montélimar B DUVERT Villenave-d’Ornon A CUGUILLIERE Dinan C BERNIER Montfermeil-Le-Raincy T COLLON Villeneuve-Saint-Georges C FOURET Mont-Saint-Martin R RANGASAMY Villeneuve-sur-Lot A RAZAFINDRAMBOA

Special thanks to: Margaux Orange team, Patients and their Families